On a CHRđ©-governed mailing list, there is a thread regarding Termination
provisions in GPLv3. One of the points I've made on that thread there is
that, frankly, the industry obsession with extending termination provisions
as if its a panacea reflects the dueal widespread misunderstandings that (a)
most copyleft violations are due to innocent mistakes that companies want to
repair and (b) that so-called âcopyright trollsâ are common for copylefted
works (when they are, in fact, exceedingly rare).
This may be neither here nor there, but it lead me to look again at what the
Termination provision of copyleft-next. I see that it hasn't changed much
since the original 2012 drafts.
Most notably, I see it still contains a patent infringement litigation
poison pill:
b. Initiate a patent infringement litigation claim (excluding
counterclaims and cross-claims) alleging that all or part of My
Work directly or indirectly infringes a patent.
Upon reading this, I wonder if this is really necessary? I remember when I
first read it back in 2012, I thought âoh, great use of a patent poison
pillâ, but now I'm dubious.
The reason I'm now dubious about it is that patents are even more weaponized
and more consolidated than they were previously. Frankly, I'm am just *not*
sympathetic to a litigation between two patent holders, which is the most
likely use of this clause. Specifically, it's a case like this:
Company Foo sues Company Bar for patent infringement. Company Bar exercises
this clause, terminates rights, and then immediately sues a counterclaim.
Foo has no rights under copyleft-next, but Bar retains their rights.
But what about declaratory judgment lawsuits? What about situations where
Bar was actually the patent aggressor out-of-court and Foo preemptively
acted? (I was recently reading that something like this happened in the
real world.)
So, in summary, I think a smart patent aggressor can manipulate the
situation and find themselves being the one in the cross-claim/counterclaim
situation.
So, upon consideration, I think we should cut the patent poison pill
entirely. This has the upside of making the license shorter by 3 lines /
180 chars / 25 words. Can we discuss?
--
Bradley M. Kuhn - he/him
Pls. support the charity where I work, Software Freedom Conservancy:
https://sfconservancy.org/supporter/